9th World Bispecific Summit is organized by Hanson Wade and will be held during Sep 18 - 20, 2018 at Wyndham Boston Beacon Hill, Boston, Massachusetts, United States Of America.
As the only event to focus exclusively on bispecifics, the World Bispecific Summit 2018 will offer a greater breadth and depth of technical content than any other conference.
This content will arm you with the insights required to tackle the most challenging developmental hurdles encountered when working with these therapeutics, as well as shining a light on novel applications of bispecifics.
Join your peers to discuss strategies to select and validate synergistic targets, understand the true potential of novel formats, streamline CMC and developability processes and maximize clinical performance.
Time: 8:30 am to 5:00 pm
Prices:
Gold: Conference and 2 Workshops (Standard Rate): USD 3997.0,
Silver: Conference and 1 Workshop (Standard Rate): USD 2998.0,
Bronze: Conference Only (Standard Rate): USD 2399.0,
Workshops Individual (Standard Rate): USD 699.0
Speakers: David Poon, Zymeworks, John Desjariais, Xencor, Rakesh Dixit, MedImmune, Jijie Gu, AbbVie, John Haurum, F-Star, Ercole Rao, Sanofi, Eric Smith, Regeneron, Janine Schuurman, Genmab, Daniel Hofmann, BioNTech, Jonathan Davis, Bristol-Myers Squibb, Edward Berger, National Institutes of Health, John Blankenship, Novartis, Matthias Friedrich, Amgen, Andrea Hooper, Pfizer, Jonathan Lai, Albert Einstein College of Medicine, Robert Mabry, Cogen Therapeutics, Laura von Schantz, Alligator Bioscience
Additional details will be posted as soon as they are available.